Qiagen Registers $127.1M in Employee Stock Options | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen on Thursday filed for the registration of up to $127.1 million in shares in connection to stock options being offered to employees.

The company filed a registration for 9 million shares at a proposed maximum offering price of $14.12 in a Form S-8 filed with the US Securities and Exchange Commission.

The price was based on the average of the high and low sale prices of Qiagen's stock as of Nov. 15, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.